Lumbar Infiltration With Steroids - Effects on Pain Reduction
June 2, 2015 updated by: University of Zurich
Questionnaire for patients who got a lumbar infiltration in our clinic.
The patients will have to answer questions concerning their pain.
(The lumbar infiltration itself is not part of this study)
Study Overview
Detailed Description
Questionnaire are given to patients who got a lumbar infiltration in our clinic of rheumatology.
These patients will have to answer questions concerning their pain.
(The lumbar infiltration itself is not part of this study).
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland
- University Hospital Zurich, Division of Rheumatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who got a lumbar infiltration in our clinic.
The patients will have to answer questions concerning their pain (the lumbar infiltration itself is not part of this study).
Description
Inclusion criteria:
- Patients who got a lumbar infiltration in our clinic.
Exclusion criteria:
- Infiltration of thoracal or cervical spine.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain reduction
Time Frame: week 1 and 3; month 3, 6, 12
|
on visual analog scale
|
week 1 and 3; month 3, 6, 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sandra Blumhardt, MD, University Hospital Zurich, Division of Rheumatology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
April 5, 2011
First Submitted That Met QC Criteria
April 6, 2011
First Posted (Estimate)
April 7, 2011
Study Record Updates
Last Update Posted (Estimate)
June 3, 2015
Last Update Submitted That Met QC Criteria
June 2, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LINFRUZ01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.